@agelessmenshealth's testosterone delivery claims, fact-checked
Quick answer
The video compares oral testosterone undecanoate to injectable testosterone cypionate or enanthate for hypogonadism treatment, correctly noting food-dependent absorption for oral formulations and stable serum levels with intramuscular injections. The liver strain argument presented in the video applies to older 17-alpha alkylated oral androgens, not to FDA-approved testosterone undecanoate, which has not demonstrated clinically significant hepatotoxicity in phase III trials. Both delivery methods are legitimate options for appropriately diagnosed hypogonadal patients, with selection driven by lifestyle factors, patient preference, and clinical monitoring capacity.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.
What did @agelessmenshealth actually say?
Alex from Ageless Men's Health walked through the differences between oral and injectable testosterone, leaning hard toward injectables. He said oral testosterone has "inconsistent" absorption tied to food intake, while injections provide "more stable and sustained testosterone levels." He also claimed injections "bypass the digestive system, reducing potential liver strain" and that oral formulations are newer with less established safety data. The video ends with a call to schedule a consultation.
That's a fairly reasonable overview, but there's a specific factual error buried in the middle that undermines the whole segment, and the liver claim is more nuanced than he lets on.
Does the science back this up?
Partially. The absorption variability claim for oral testosterone is real, but the liver strain framing is outdated and doesn't apply cleanly to modern oral formulations. Injectable testosterone's efficacy profile is well-documented, but calling oral options categorically riskier is a stretch given current evidence.
Testosterone undecanoate (Jatenzo, Tlando, Kyzaiq) is the primary oral formulation approved in the U.S. These are not 17-alpha alkylated compounds, which is the older class of oral androgens actually linked to hepatotoxicity. Swerdloff et al. (2020, Journal of Clinical Endocrinology and Metabolism) showed that oral testosterone undecanoate achieved therapeutic serum levels in roughly 87% of men, with meal-dependent absorption being a real but manageable variable. The liver signal in that trial was not clinically significant.
For injectables, the evidence base is stronger simply because testosterone cypionate and enanthate have been used for decades. Bhasin et al. (2010, NEJM) remains a key reference for injectable testosterone's efficacy in hypogonadal men, confirming stable trough levels with weekly or biweekly dosing.
What did they get wrong (or right)?
There is a clear scripting error in this video that should not go unaddressed. Alex says "oral testosterone is intramuscularly administered" when he visibly means to say injectable testosterone. That is a factual mix-up that could genuinely confuse viewers who are early in researching TRT options.
On the liver claim: the framing that injectables reduce "liver strain associated with oral medications" is misleading when applied to FDA-approved oral testosterone undecanoate. That liver risk narrative comes from older, alkylated oral androgens like methyltestosterone, which are largely off the market. Saying modern oral testosterone carries liver risk without that distinction is not accurate.
What he got right: food-dependent absorption for oral testosterone undecanoate is real and documented. The FDA label for Jatenzo specifically requires administration with food. He also appropriately deferred to healthcare providers for treatment decisions, which is the correct call.
What should you actually know?
If you are comparing oral and injectable testosterone, the actual decision points are more practical than the video suggests. Injection frequency, needle comfort, and consistent scheduling matter for injectables. Meal timing and the twice-daily dosing schedule matter for oral options. Neither form is universally superior.
The liver concern is largely a non-issue with approved oral testosterone undecanoate at therapeutic doses, based on current trial data. If a provider or content creator is still invoking the liver argument to steer you away from oral testosterone, ask them specifically which formulation they mean. Alkylated oral androgens and modern testosterone undecanoate are not the same thing.
A 2022 review by Khera et al. in Urology Clinics of North America noted that both delivery methods can achieve symptom relief in hypogonadal men when dosed appropriately, and that patient preference and lifestyle factors should be weighted heavily in the choice. That is a more accurate frame than "injectables are more stable, therefore better."
- Oral testosterone undecanoate is FDA-approved and does not carry the same hepatotoxicity risk as older alkylated oral androgens.
- Injectable testosterone has a longer evidence base, but that reflects history of availability, not inherent superiority.
- Absorption variability with oral TRT is real, but manageable with consistent meal timing.
- The "intramuscularly administered" line in the video was a scripting error that reversed the route of administration.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 8 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For @agelessmenshealth's testosterone delivery claims, fact-checked, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Cardiovascular Safety of Testosterone-Replacement Therapy
TRAVERSE trial anchor for cardiovascular-safety discussions in appropriately diagnosed men.
PubMed
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
Guideline anchor for diagnosis, monitoring, contraindications, and appropriate TRT framing.
PubMed
NAD+ metabolism and its roles in cellular processes during ageing
Core review for NAD+ decline, mitochondrial function, DNA repair, and aging biology.
PubMed
Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women
Human NMN source for metabolic claims while keeping population limits clear.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
@agelessmenshealth's testosterone delivery claims, fact-checked is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
Compare providers, services and access requirements in the directory before contacting a suitable care team.
Claim path
Keep researching this testosterone and trt video claims cluster
Best for searchers turning TRT social claims into a safer lab-backed provider discussion.
Claim verdict
The useful answer behind this video
Claim being checked
The video compares oral testosterone undecanoate to injectable testosterone cypionate or enanthate for hypogonadism treatment, correctly noting food-dependent absorption for oral formulations and stable serum levels with intramuscular injections.
FormBlends verdict
The video compares oral testosterone undecanoate to injectable testosterone cypionate or enanthate for hypogonadism treatment, correctly noting food-dependent absorption for oral formulations and stable serum levels with intramuscular injections. The liver strain argument presented in the video applies to older 17-alpha alkylated oral androgens, not to FDA-approved testosterone undecanoate, which has not demonstrated clinically significant hepatotoxicity in phase III trials. Both delivery methods are legitimate options for appropriately diagnosed hypogonadal patients, with selection driven by lifestyle factors, patient preference, and clinical monitoring capacity.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- The video compares oral testosterone undecanoate to injectable testosterone cypionate or enanthate for hypogonadism treatment, correctly noting food-dependent absorption for oral formulations and stable serum levels with intramuscular injections. The liver strain argument presented in the video applies to older 17-alpha alkylated oral androgens, not to FDA-approved testosterone undecanoate, which has not demonstrated clinically significant hepatotoxicity in phase III trials. Both delivery methods are legitimate options for appropriately diagnosed hypogonadal patients, with selection driven by lifestyle factors, patient preference, and clinical monitoring capacity.
- FDA-approved oral testosterone undecanoate (Jatenzo, Tlando) is not the same as older alkylated oral androgens; the liver toxicity risk commonly cited does not apply to the current approved formulations per Swerdloff et al. (2020, JCEM).
- Swerdloff et al. (2020) found oral testosterone undecanoate achieved therapeutic serum levels in approximately 87% of men, with food-dependent absorption being manageable rather than prohibitive.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- FDA-approved oral testosterone undecanoate (Jatenzo, Tlando) is not the same as older alkylated oral androgens; the liver toxicity risk commonly cited does not apply to the current approved formulations per Swerdloff et al. (2020, JCEM).
- Swerdloff et al. (2020) found oral testosterone undecanoate achieved therapeutic serum levels in approximately 87% of men, with food-dependent absorption being manageable rather than prohibitive.
- The video contains a clear factual error: Alex states oral testosterone is intramuscularly administered, which reverses the actual route of administration.
- Bhasin et al. (2010, NEJM) established that intramuscular testosterone injections produce stable trough levels with weekly or biweekly dosing, supporting the stability claim for injectables.
- Khera et al. (2022, Urology Clinics of North America) concluded that both oral and injectable testosterone can achieve symptom relief in hypogonadal patients, with delivery method selection driven by patient lifestyle and preference.
- The twice-daily dosing requirement and meal timing for oral testosterone undecanoate are real practical considerations, but they are management factors, not evidence of inferiority to injectables.
- Neither oral nor injectable testosterone is appropriate without a confirmed diagnosis of hypogonadism through clinical evaluation and laboratory testing.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Ageless Men's Health® | TRT & Weight Loss Experts · Instagram creator
11.2K views on this video
Oral vs. Injectable Testosterone—Which is Right for You? 💉💊 Oral testosterone requires careful meal timing and can have inconsistent absorption, while injectable testosterone delivers more stable,
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by Ageless Men's Health® | TRT & Weight Loss Experts, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.